Survey of Hepatitis C virus infection in Punjab
Not Applicable
- Registration Number
- CTRI/2013/08/003910
- Lead Sponsor
- MSD Pharmaceuticals Private Limited A subsidiary of Merck Co Inc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 5500
Inclusion Criteria
Household members greater than five years of age who have provided voluntary informed consent for participation (For adults aged more than 18 years informed consent will be taken. For
children aged more than 5 years and less than 18 years, assent along with
informed consent by parents or legally acceptable
representative [LAR] will be taken).
Exclusion Criteria
Children aged less than 5 years
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of this survey is the prevalence of HCV infection in general population of Punjab. The primary outcome analyzed for HCV infection will be derived from the results of <br/ ><br>markers of HCV infection, anti-HCV (screening assay) and HCV RNA.Timepoint: Twelve months
- Secondary Outcome Measures
Name Time Method To identify the risk factors for HCV infection in Punjab <br/ ><br> <br/ ><br>To assess the prevalence of other hepatotropic viruses in <br/ ><br>PunjabTimepoint: Twelve months